Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 41

Results For "ASA"

521 News Found

Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
Biotech | April 08, 2022

Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment

Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting


AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain
News | April 06, 2022

AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain

The new facility is scheduled to start operation in the first half of 2024


Good microbiome and probiotics key to good health
Healthcare | April 04, 2022

Good microbiome and probiotics key to good health

The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram


Lonza Joins International Pharmaceutical Aerosol Consortium
News | April 01, 2022

Lonza Joins International Pharmaceutical Aerosol Consortium

Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies


FDI World Dental Federation releases statement on sustainable oral healthcare
Sustainability | March 31, 2022

FDI World Dental Federation releases statement on sustainable oral healthcare

It paves the way for an industry Code of Good Practice


Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Drug Approval | March 30, 2022

Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors

Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


Dupixent is a star in Sanofi’s immunology strategy
Biotech | March 29, 2022

Dupixent is a star in Sanofi’s immunology strategy

Dupixent peak sales ambition raised to more than €13 billion


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project